NeuroOne Medical Technologies Corporation
Price Action
Technical Summary
WEAKENINGNeuroOne Medical Technologies Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 47), showing significant lag compared to the market leaders. Earnings contraction of 149% provides fundamental context to the price action. Investors should exercise caution due to high volatility (112% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.63 | -1.99% | BELOW |
| 50 SMA | $4.61 | -1.42% | BELOW |
| 100 SMA | $4.70 | -3.44% | BELOW |
| 150 SMA | $4.67 | -2.73% | BELOW |
| 200 SMA | $4.75 | -4.42% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NMTC in an uptrend right now?
NMTC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is NMTC overbought or oversold?
NMTC's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is NMTC outperforming the market?
NMTC has a Relative Strength (RS) Rating of 47 out of 99. NMTC is currently lagging the broader market.
Where is NMTC in its 52-week range?
NMTC is trading at $4.54, which is 65% of its 52-week high ($6.96) and 60% above its 52-week low ($0.85).
How volatile is NMTC?
NMTC has a Beta of 0.74 and 52-week volatility of 112%. It's less volatile than the S&P 500 - generally more stable.